Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 2010

Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
Dipartimento Farmaco-Chimico, UniversitĂ  di Messina, Viale Annunziata, 98168 Messina, Italy. ammonforte@pharma.unime.it

A series of novel benzimidazolones and their analogues, characterized by the presence of one or more methyl groups or other bioisosteric moieties at different positions of the phenyl ring at N-1, were synthesized and evaluated as inhibitors of human immunodeficiency virus type-1 (HIV-1). Most of the new compounds proved to be highly effective in inhibiting both HIV-1 replication in MT4 cells with minimal cytotoxicity and RT enzyme at nanomolar concentrations. Some derivatives were also tested against RTs containing single amino acid mutations responsible for resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs). The different potencies displayed by the new compounds were studied using molecular modeling.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
October 2019, Molecules (Basel, Switzerland),
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
August 2004, Antiviral research,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
July 2013, ChemMedChem,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
July 2017, Bioorganic & medicinal chemistry,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
February 2019, ACS medicinal chemistry letters,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
February 2004, Journal of medicinal chemistry,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
January 2008, Bioorganic & medicinal chemistry letters,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
June 2014, Bioorganic & medicinal chemistry,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
February 2016, Chemical biology & drug design,
Anna-Maria Monforte, and Patrizia Logoteta, and Laura De Luca, and Nunzio Iraci, and Stefania Ferro, and Giovanni Maga, and Erik De Clercq, and Christophe Pannecouque, and Alba Chimirri
October 2008, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!